JPS5951998B2 - New physiologically active substance betenone B and its production method - Google Patents
New physiologically active substance betenone B and its production methodInfo
- Publication number
- JPS5951998B2 JPS5951998B2 JP57100728A JP10072882A JPS5951998B2 JP S5951998 B2 JPS5951998 B2 JP S5951998B2 JP 57100728 A JP57100728 A JP 57100728A JP 10072882 A JP10072882 A JP 10072882A JP S5951998 B2 JPS5951998 B2 JP S5951998B2
- Authority
- JP
- Japan
- Prior art keywords
- active substance
- physiologically active
- bethenone
- tables
- chemical formulas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compounds Of Unknown Constitution (AREA)
Description
【発明の詳細な説明】
本発明は新規生理活性物質ベーテノンBおよびその製造
法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel physiologically active substance bethenone B and a method for producing the same.
本発明者らは、新規な生理活性物質の探索を目的として
ホマ・ベーテ(PhOmabetae)に属する微生物
を適宜の培地に培養することによつて、植物種子生育阻
害活性を示す物質EA−B−DG−14を培地中に蓄積
しうることを知り、この生理活性物質を単離し、その物
理化学的および生物学的性質から、当該生理活性物質が
新規な生理活性物質であることを認め、これを生理活性
物質ベーテノンB(BetaenOneB)と命名し、
以下生理活性物質ベーテノンBと称することにした。For the purpose of searching for new physiologically active substances, the present inventors cultivated microorganisms belonging to the Phomabetae family in an appropriate medium, and found that EA-B-DG, a substance that exhibits plant seed growth inhibitory activity, -14 could accumulate in the culture medium, isolated this physiologically active substance, recognized that it is a new physiologically active substance based on its physicochemical and biological properties, and recognized this physiologically active substance. Physiologically active substance Betaenone B (BetaenOneB)
Hereinafter, it will be referred to as the physiologically active substance bethenone B.
すなわち本発明は、(1)生理活性物質ベーテノンB、
(2)ホマ・ベーテに属する生理活性物質ベーテノンB
生産菌を培地に培養し、培養物中に生理活.性物質ベー
テノンBを生成蓄積せしめ、これを採取することを特徴
とする生理活性物質ベーテノンBの製造法である。That is, the present invention provides (1) a physiologically active substance bethenone B;
(2) Bethenone B, a physiologically active substance belonging to Homa Bethe
The producing bacteria are cultured in a medium, and physiological activities are detected in the culture. This is a method for producing the physiologically active substance bethenone B, which is characterized by producing and accumulating the physiologically active substance bethenone B, and collecting the same.
なお、以下生理活性物質ベーテノンBを単に「ベーテノ
ンB」と称することもある。Note that hereinafter, the physiologically active substance bethenone B may be simply referred to as "bethenone B."
本発明の生理活性物質ベーテノンBを製造するにあたつ
ては、ホマ・ベーテに属する生理活性物質ベーテノンB
生産菌が用いられる。In producing the physiologically active substance bethenone B of the present invention, the physiologically active substance bethenone B belonging to Homa Bethe
Production bacteria are used.
一例として、ホマ・ベーテ・ブランクPS−13(Ph
OmabetaeFrankPS−13)として、工業
技術院微生.物工業技術研究所に寄託されている微生物
が用いられる (微工研菌寄第6556号)。この発明
で使用するホマ・ベーテに属する生理活性物質ベーテノ
ンB生産菌は例えば紫外線、X線などの照射処理、変異
誘起剤による処理等によ一つて生産能を高めて使用でき
ることは、いうまでもなく、本発明で使用しうる菌株は
、ホマ・ベーテに属し、生理活性物質ベーテノンBを生
産する菌株をすべて包含するものである。As an example, Homa Bete Blank PS-13 (Ph
As OmabetaeFrankPS-13), Institute of Industrial Science and Technology Microbiology. Microorganisms deposited with the Institute of Industrial Science and Technology are used (Feikoken Bacterial Submission No. 6556). It goes without saying that the bacteria producing betenone B, a physiologically active substance belonging to the Homa bethe group used in this invention, can be used by increasing its production capacity by, for example, being irradiated with ultraviolet rays or X-rays, or treated with a mutagenic agent. However, the strains that can be used in the present invention include all strains that belong to Homa bethe and produce the physiologically active substance betenone B.
本発明の生理活性物質を製造する方法における培養は前
記菌株を、利用可能な栄養物を含有する培地で行なわれ
る。In the method for producing a physiologically active substance of the present invention, the strain is cultured in a medium containing available nutrients.
培地組成としては、たとえばじやがいも煎汁、澱粉、グ
リセリン、デキストリン、しよ糖、麦芽糖、ブドウ糖等
の炭素源、ペプトン、肉工キズ、酵母工キズ、カゼイン
加水分解物、コーン・スチーブ・りカー、グルテンミー
ル、コーンミール、大豆粉、小麦胚芽、綿実粉、硫酸ア
ンモニウム、燐酸アンモニウム、尿素等の窒素源が用い
られる。また、必要に応じて炭酸カルシウム、燐酸2水
素カリウム、燐酸水素2カリウム、塩化マグネシウム、
塩化ナトリウム等の無機塩が添加される。培養温度は2
0〜30℃が適当である。種培養は固体培養でも液体培
養でもよい。本培養の場合は静置培養、攪拌培養、振盪
培養、通気培養等いずれを実施してもよい。培地の惧は
4〜8の範囲でおよそ3 〜15日間培養するが、培養
の途中において目的物質の生成量を測定し、培地中に実
質的な量が生産されていることを確認して培養を終了す
る。生成したベーテノンBは主に培養戸液中に存在する
ので、遠心分離または濾過により菌体を除去した後、そ
の上清液から精製、採取される。The medium composition includes, for example, a decoction of yam and potatoes, starch, glycerin, dextrin, carbon sources such as sucrose, maltose, and glucose, peptone, meat-processing scratches, yeast-processing scratches, casein hydrolyzate, corn, stew, etc. Nitrogen sources such as alcohol, gluten meal, corn meal, soybean flour, wheat germ, cottonseed flour, ammonium sulfate, ammonium phosphate, and urea are used. In addition, calcium carbonate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, magnesium chloride,
Inorganic salts such as sodium chloride are added. The culture temperature is 2
A temperature of 0 to 30°C is suitable. The seed culture may be a solid culture or a liquid culture. In the case of main culture, static culture, agitation culture, shaking culture, aerated culture, etc. may be performed. The culture medium is cultured for approximately 3 to 15 days with a medium concentration of 4 to 8. During the culture, the amount of the target substance produced is measured to confirm that a substantial amount has been produced in the medium, and then the culture is continued. end. Since the produced Bethenone B mainly exists in the culture liquid, it is purified and collected from the supernatant liquid after removing bacterial cells by centrifugation or filtration.
ベーテノンBを精製採取するには、通常微生物の代謝産
物を採取するのに用いられている手段を適宜利用するこ
とができる。例えば減圧濃縮、凍結乾燥、溶媒抽出、樹
脂による処理、吸着剤による処理、結晶化、再結晶等の
手段を単独、あるいは任意の順序に組み合わせ、または
反復して戸液から目的物質の分離・精製・採取を行なう
。さらに具体的にその一例を述べるならば、培養終了後
、培養液を濾過補助剤を用いて濾過し、菌体を除去する
。In order to purify and collect Bethenone B, the means normally used for collecting metabolites of microorganisms can be appropriately used. For example, separation and purification of the target substance from the liquid may be carried out singly, in combination in any order, or repeatedly using methods such as vacuum concentration, freeze drying, solvent extraction, resin treatment, adsorbent treatment, crystallization, and recrystallization.・Collect data. To give a more specific example, after completion of the culture, the culture solution is filtered using a filter aid to remove bacterial cells.
得られた濾液を減圧下で濃縮し、濃縮液の山を氷酢酸に
て約IIfI5.5〜6.5に調整した後、ベーテノン
Bを溶解せしめる有機溶媒たとえば酢酸エチルを添加し
て抽出する。ここで得られた抽出物(酢酸エチル層)を
減圧下で濃縮し、たとえばシリカゲルの如き吸気剤を用
いたクロマトグラフイ一にかける。吸着剤としてシリカ
ゲルを用いた場合には、溶出溶媒にクロロホルム、メタ
ノールの混合溶媒系を用いて展開・溶出する。溶出液を
適宜分画し、目的物質を含む画分を集め、減圧下低温で
濃縮乾固して粗物質を得る。得られた粗物質を更に精製
するため、再度シリカゲルクロマトグラフイ一にかけて
不純物が除去される。後述の実施例1で得られたベーテ
ノンBの物理化学的性状は次の通りである。(1)形状
:白色粉末
(2)比旋光度: 〔α〕LO=0゜(C=1.0、エ
タノール)(3)分子式:C2lH36O5
この分子式は、後述のようにベーテノンBのアセチル化
物より推定したもの(4)紫外部吸収スペクトル:
墨輿11^ ?VV− − \−v−● v
ノ(5)赤外部吸収スペクトル(主要ピーク):(6)
薄層タロマトグラフイ一〔シリカゲル(メルタ社製)使
用〕溶媒系 Rf値タロ
ロホルムリメタノール(9:1,VN)0.37(7)
溶解性:
可溶;メタノール、エタノール、タロロホルム、酢酸エ
チル不溶;n−ヘキサン、水
(8)呈色反応:
シリカゲル薄層クロマト上で゛アニスアルデヒド試薬で
青一青緑色を呈する。The resulting filtrate is concentrated under reduced pressure, and the concentrated solution is adjusted to IIfI of about 5.5 to 6.5 with glacial acetic acid, and then extracted with an organic solvent capable of dissolving bethenone B, such as ethyl acetate. The extract (ethyl acetate layer) obtained here is concentrated under reduced pressure and subjected to chromatography using a suction agent such as silica gel. When silica gel is used as an adsorbent, a mixed solvent system of chloroform and methanol is used as the elution solvent for development and elution. The eluate is appropriately fractionated, fractions containing the target substance are collected, and the fractions are concentrated to dryness under reduced pressure at low temperature to obtain a crude substance. In order to further purify the obtained crude material, it is again subjected to silica gel chromatography to remove impurities. The physicochemical properties of Bethenone B obtained in Example 1 described below are as follows. (1) Shape: White powder (2) Specific rotation: [α] LO = 0° (C = 1.0, ethanol) (3) Molecular formula: C2lH36O5 This molecular formula is derived from the acetylated product of bethenone B as described below. Estimated (4) Ultraviolet absorption spectrum: Bikoshi11^? VV- - \-v-● v
(5) Infrared absorption spectrum (main peak): (6)
Thin layer talomatography (using silica gel (manufactured by Melta)) Solvent system Rf value taloloformrimethanol (9:1, VN) 0.37 (7)
Solubility: Soluble; Insoluble in methanol, ethanol, taloloform, ethyl acetate; N-hexane, water (8) Color reaction: Obtains blue-blue green color with anisaldehyde reagent on silica gel thin layer chromatography.
(9)核磁気共鳴スペクトル: さらに、ベーテノンBのアセチル化物について述べる。(9) Nuclear magnetic resonance spectrum: Furthermore, the acetylated product of bethenone B will be described.
すなわち、ベーテノンBをピリジン中無水酢酸にて常法
によりアセチル化すると、ベーテノンBアセテートが結
晶(融点103.5〜108.0℃)として得られる。
かかるベーテノンBアセテートについて元素分析を行な
つた結果は次の通りで、FOundC:67.25%,
H9.42%
Caled
C:67.29%,H:9.61%
分子式C23H38O6と示され、従つてベーテノンB
の分子式はC2lH36O.と推定された。That is, when Bethenone B is acetylated with acetic anhydride in pyridine by a conventional method, Bethenone B acetate is obtained as crystals (melting point: 103.5 to 108.0°C).
The results of elemental analysis of Bethenone B acetate are as follows: FOundC: 67.25%;
H9.42% Caled C: 67.29%, H: 9.61% Molecular formula is C23H38O6, therefore betenone B
The molecular formula of C2lH36O. It was estimated that
次に、ベーテノンBの生物学的性質について述べる。す
なわち、生理活性試験として、シヤーレに濾紙を入れ、
試料1mgを酢酸エチルに溶解させ、淵紙に均一にしみ
込ませて風乾した後、吸引デシケータ一中で5時間乾燥
させる。Next, the biological properties of bethenone B will be described. In other words, as a physiological activity test, a filter paper was placed in a shear dish,
Dissolve 1 mg of the sample in ethyl acetate, apply it uniformly to Fuchi paper, air dry, and then dry in a suction desiccator for 5 hours.
これに蒸留水4m1を加え、250p罰水溶液とし、P
紙上にレタス種子22粒を播き、密閉容器に入れ、25
℃暗室にて72時間静置した後、幼根長および胚軸長を
測定し、次の式にて種子生育阻害率を求めた。その結果
、ベーテノンBは、20%の幼根生育阻害率及び3%の
胚軸生育阻害率を示すことがわかつた。Add 4ml of distilled water to this to make a 250p aqueous solution,
Sow 22 lettuce seeds on paper, put them in an airtight container,
After standing in a dark room for 72 hours, the radicle length and hypocotyl length were measured, and the seed growth inhibition rate was calculated using the following formula. As a result, it was found that Bethenone B exhibited a radicle growth inhibition rate of 20% and a hypocotyl growth inhibition rate of 3%.
このような性質は、同じ菌株のホマ・ベーテにより生産
されるDNAポリメラーゼαの特異的阻害剤アフイデイ
コリンにおいても認められていることから、ベーテノン
Bにおいても他の生理活性の存在が推定され、農薬・医
薬としての利用が期待されるものである。なお、生理活
性物質ベーテノンBの検出および定量法は、シリカゲル
薄層クロマトグラフイ一(タルク社製シリカゲル60F
。These properties have also been observed in aphideicorin, a specific inhibitor of DNA polymerase α produced by the same strain of Homa bethe, so it is presumed that bethenone B also has other physiological activities, and it is believed that bethenone B also has other physiological activities. It is expected to be used as a medicine. The physiologically active substance bethenone B was detected and quantified using silica gel thin layer chromatography (silica gel 60F manufactured by Talc).
.
。。厚さ0.2mm,展開溶媒;クロロホルムリメタノ
ール=9:1,V/V)発色剤; 2,4−DNP試薬
,加熱)によつた。次に、本発明の実施例を示す。実施
例 1
微生物としてホマ・ベーテ・ブランク・ PS一13株
(PhOmabetaeFrankPS−13;微工研
菌寄第6556号)を使用し、次に示す種培地に接種し
、25℃,10日間前培養を行なつた。. . Thickness: 0.2 mm, developing solvent: chloroformrimethanol = 9:1, V/V) color former: 2,4-DNP reagent, heating). Next, examples of the present invention will be shown. Example 1 Phomabetae Frank PS-13 strain (Phomabetae FrankPS-13; Microtechnical Research Institute No. 6556) was used as a microorganism, inoculated into the following seed medium, and precultured at 25°C for 10 days. I did it.
種培地:表皮を剥いたじやがいも200gを1cm角に
切り、水道水約11を加え、オートクレープ(1kg/
Cm2,lO分間)にて加熱処理し、煎汁をガーゼ4枚
で沢過し、11を得る。Seed medium: Cut 200 g of peeled yams into 1 cm cubes, add about 11 g of tap water, and autoclave (1 kg/
The decoction was filtered through four pieces of gauze to obtain 11.
これにしよ糖20g、粉末寒天20gを加え、更に5分
間オートクレーブにて加熱して溶解させる。次に、前培
養を行なつた種菌を、500m1容フラスコあたり15
0m1を分注殺菌した本培養培地に白金耳にて接種し、
25℃で15日間静置培養を行なつた。Add 20 g of sugar and 20 g of powdered agar to this, and heat in an autoclave for an additional 5 minutes to dissolve. Next, the pre-cultured inoculum was added at 15 ml per 500 ml flask.
Dispense 0ml into sterilized main culture medium using a platinum loop,
Static culture was performed at 25°C for 15 days.
Claims (1)
形状:白色粉末(2)比旋光度:〔α〕_D^2^0=
0°(c=1.0、エタノール)(3)分子式: 推定分子式:C_2_1H_3_6O_5(4)紫外部
吸収スペクトル: ▲数式、化学式、表等があります▼ (5)赤外部吸収スペクトル(主要ピーク):▲数式、
化学式、表等があります▼▲数式、化学式、表等があり
ます▼ (6)薄膜クロマトグラフィー〔シリカゲル(メルク社
製)使用〕:溶媒系Rf値 クロロホルム:メタノール(9:1V/V)0.37(
7)溶解性: 可溶;メタノール、エタノール、クロロホルム、酢酸エ
チル不溶;n−ヘキサン、水 (8)呈色反応: シリカゲル薄層クロマト上でアニスアルデヒド試薬で青
−青緑色を呈する(9)核磁気共鳴スペクトル: ▲数式、化学式、表等があります▼ 0.669(3H、d、J=6.35 Hz)、 0.863(3H、t、J=7Hz) 1.106(1H、s)、 1.151(1H、d、J=6.84 Hz)、 1.261(3H、s)、 1.319(1H、t、J=13.19 Hz)、 1.404(3H、s)、 1.4−1.5(2H、m)、 1.554(1H、s)、 1.567(3H、s)、 1.605(1H、s)、 1.837(2H、m)、 2.307(1H、dt、J=14Hz、3Hz)、 2.493(1H、t)、 2.66−2.69(2H、m)、 2.817(1H、dt)、 3.110(1H、dq)、 3.658(1H、s)、 3.76−3.85(1H、m)、 3.87−3.97(1H、m)、 2 ホマ・ベーテ(Phoma betae)に属する
生理活性物質ベーテノンB生産菌を栄養培地に培養し、
培養物中に生理活性物質ベーテノンBを生成蓄積せしめ
、これを採取することを特徴とする生理活性物質ベーテ
ノンBの製造法。[Claims] 1. Physiologically active substance bethenone B (1) having the following properties:
Shape: White powder (2) Specific rotation: [α]_D^2^0=
0° (c=1.0, ethanol) (3) Molecular formula: Estimated molecular formula: C_2_1H_3_6O_5 (4) Ultraviolet absorption spectrum: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (5) Infrared absorption spectrum (main peak): ▲Math,
There are chemical formulas, tables, etc. ▼▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (6) Thin film chromatography [using silica gel (manufactured by Merck & Co.)]: Solvent system Rf value Chloroform: Methanol (9:1 V/V) 0.37 (
7) Solubility: Soluble; Insoluble in methanol, ethanol, chloroform, ethyl acetate; N-hexane, water (8) Color reaction: On silica gel thin layer chromatography, exhibits blue-blue green color with anisaldehyde reagent (9) Nuclei Magnetic resonance spectrum: ▲ Contains mathematical formulas, chemical formulas, tables, etc. ▼ 0.669 (3H, d, J = 6.35 Hz), 0.863 (3H, t, J = 7Hz) 1.106 (1H, s) , 1.151 (1H, d, J = 6.84 Hz), 1.261 (3H, s), 1.319 (1H, t, J = 13.19 Hz), 1.404 (3H, s) , 1.4-1.5 (2H, m), 1.554 (1H, s), 1.567 (3H, s), 1.605 (1H, s), 1.837 (2H, m), 2.307 (1H, dt, J=14Hz, 3Hz), 2.493 (1H, t), 2.66-2.69 (2H, m), 2.817 (1H, dt), 3.110 ( 1H, dq), 3.658 (1H, s), 3.76-3.85 (1H, m), 3.87-3.97 (1H, m), 2 Belongs to Phoma betae Cultivating bacteria producing the physiologically active substance bethenone B in a nutrient medium,
1. A method for producing the physiologically active substance bethenone B, which comprises producing and accumulating the physiologically active substance bethenone B in a culture and collecting the same.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57100728A JPS5951998B2 (en) | 1982-06-14 | 1982-06-14 | New physiologically active substance betenone B and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57100728A JPS5951998B2 (en) | 1982-06-14 | 1982-06-14 | New physiologically active substance betenone B and its production method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58220686A JPS58220686A (en) | 1983-12-22 |
| JPS5951998B2 true JPS5951998B2 (en) | 1984-12-17 |
Family
ID=14281667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57100728A Expired JPS5951998B2 (en) | 1982-06-14 | 1982-06-14 | New physiologically active substance betenone B and its production method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5951998B2 (en) |
-
1982
- 1982-06-14 JP JP57100728A patent/JPS5951998B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58220686A (en) | 1983-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1046439A (en) | Physiologically active substances from penicillium citrinum | |
| JPH02196780A (en) | Glycosidase-inhibitor sarbostatin and its manufacture | |
| JPS6310953B2 (en) | ||
| JPS5951998B2 (en) | New physiologically active substance betenone B and its production method | |
| JP2873894B2 (en) | Cyclic depsipeptide and method for producing the same | |
| JPS5951999B2 (en) | New physiologically active substance betenone A and its production method | |
| JP2936663B2 (en) | Method for producing FR901228 substance | |
| JP3436699B2 (en) | Novel substances FH-1 and FH-2, their production methods and antibacterial agents containing them as active ingredients | |
| JP3030896B2 (en) | WB968 substance group and production method thereof | |
| JPS5952000B2 (en) | Novel physiologically active substance 3-deoxyafuidicorin and its production method | |
| JP2578486B2 (en) | New substance KS-502 | |
| JPS60218396A (en) | Antibiotic do-248-a and do-248-b and preparation thereof | |
| JPS61289005A (en) | Plant pathogenic germ sporulation inhibitor | |
| JPS61289898A (en) | Production of factor for suppressing sporulation of phytopathogenic fungus | |
| JPS62210996A (en) | Production of antibiotic substance emimycin | |
| JPS608795B2 (en) | Method for producing aphidicolin and/or its derivatives | |
| JPS6322583A (en) | Si-4228 based substance and germicide containing said substance as active ingredient | |
| JPS5932120B2 (en) | Method for producing 9-β-D arabinofuranosyl adenine | |
| JPS5945894A (en) | Preparation of coenzyme q10 | |
| JPH03206890A (en) | Antibiotic tan-1,254 and production thereof | |
| JPH0359912B2 (en) | ||
| JPH0296569A (en) | Novel physiologically active substance leuhistin and production thereof | |
| JPS5830038B2 (en) | Production method of coenzyme Q↓1↓0 | |
| JPS5828293A (en) | Preparation of mitomycins | |
| JPS61152693A (en) | Anthracycline, r20x10, and its use |